EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening and surveillance practices for Multiple Endocrine Neoplasia type 1‐related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence ( ENETS CoE )—An ENETS MEN1 task force questionnaire study

Carolina R C Pieterman iD, Simona Grozinsky-Glasberg iD, Dermot O'Toole iD, James R Howe iD, Valentina Ambrosini iD, Susana H Belli, Mikkel Andreassen iD, Nehara Begum iD, Timm Denecke iD, Antongiulio Faggiano iD, Massimo Falconi iD, Jo Grey und 17 weitere

Journal of Neuroendocrinology · 2025-01 · 37 (1)

DOI: 10.1111/jne.13468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 26.11.2024. Verfasst von Carolina R C Pieterman und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 1, Neuroendocrine Tumors, Early Detection of Cancer. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation in practices. Evidence on the natural course of MEN1‐related neuroendocrine tumours (NET) and the value of screening programs has increased and new imaging techniques have emerged. The aim of this study is to provide insight in the current practices of screening and surveillance for MEN1‐related NETs in ENETS Centers of Excellence (CoEs). A clinical practice questionnaire was distributed among all 65 ENETS CoEs. Response rate was 91% (59/65). In 14% of CoEs 100 patients with MEN1 are seen. Practices with regard to screening and surveillance of NETs were markedly heterogeneous. Differences between countries were noted in the use of gut hormones for biochemical screening and the choice for imaging modality for screening/surveillance of pancreatic NETs (PanNETs). Magnetic resonance imaging (MRI) is the preferred modality for screening and surveillance of PanNETs, whereas this is computed tomography (CT) for thoracic NETs. Practices regarding screening for thoracic NETs were more homogeneous among larger volume CoEs, with longer screening intervals. The majority of CoEs tailored the surveillance of small pancreatic and lung NETs to observed growth rate. 68% of CoEs advise patients with clinical MEN1 with negative genetic testing to undergo periodic screening like mutation‐positive patients. In conclusion, there is still marked heterogeneity in practice, although there are also common trends. Differences were sometimes associated with volume or country, but often no association was found. This underscores the need for clear and evidence‐based practice recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Endocrine Neoplasia Type 1Neuroendocrine TumorsEarly Detection of CancerHumansSurveys and QuestionnairesEuropeMaleFemaleMass Screening

Stichwörter der Autor:innen

multiple endocrine neoplasia type 1neuroendocrine tumourscreeningsurveillancesurvey

Autor:innen und Institutionen

  • Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Neuroendocrine Unit, ENETS Center of Excellence, Division of Medicine, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
  • Department of Clinical Medicine, St James Hospital, Trinity College Dublin & National Centre for Neuroendocrine Tumours, St Vincent's University Hospital, Dublin, Ireland.
  • University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
  • Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

ORCID-Profile: Carolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, James R Howe, Valentina Ambrosini, Mikkel Andreassen, Nehara Begum, Timm Denecke, Antongiulio Faggiano, Massimo Falconi, Ulrich P Knigge, Bruno Niederle, Els Nieveen van Dijkum, Stefano Partelli, Guido Rindi, Stefan Stättner, Timon Vandamme, Juan W Valle, Marie-Pierre Vullierme, Aurel Perren, Detlef K Bartsch, Gregory K Kaltsas, Gerlof D Valk

Zitieren

APA

Pieterman, C. R. C., Grozinsky-Glasberg, S., O'Toole, D., Howe, J. R., Ambrosini, V., Belli, S. H., Andreassen, M., Begum, N., Denecke, T., Faggiano, A., Falconi, M., Grey, J., Knigge, U. P., Kolarova, T., Niederle, B., Nieveen van Dijkum, E., Partelli, S., Pascher, A., Rindi, G., …, & Valk, G. D. (2025). Screening and surveillance practices for Multiple Endocrine Neoplasia type 1‐related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence ( ENETS CoE )—An ENETS MEN1 task force questionnaire study. Journal of Neuroendocrinology, 37(1). https://doi.org/10.1111/jne.13468

Vancouver

Pieterman CRC, Grozinsky-Glasberg S, O'Toole D, Howe JR, Ambrosini V, Belli SH, et al. Screening and surveillance practices for Multiple Endocrine Neoplasia type 1‐related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence ( ENETS CoE )—An ENETS MEN1 task force questionnaire study. Journal of Neuroendocrinology. 2025;37(1). doi:10.1111/jne.13468

BibTeX
@article{Pieterman2025,
  author = {Pieterman, Carolina R C and Grozinsky-Glasberg, Simona and O'Toole, Dermot and Howe, James R and Ambrosini, Valentina and Belli, Susana H and Andreassen, Mikkel and Begum, Nehara and Denecke, Timm and Faggiano, Antongiulio and Falconi, Massimo and Grey, Jo and Knigge, Ulrich P and Kolarova, Teodora and Niederle, Bruno and Nieveen van Dijkum, Els and Partelli, Stefano and Pascher, Andreas and Rindi, Guido and Ruszniewski, Philippe and Stättner, Stefan and Vandamme, Timon and Valle, Juan W and Vullierme, Marie-Pierre and Welin, Staffan and Perren, Aurel and Bartsch, Detlef K and Kaltsas, Gregory K and Valk, Gerlof D},
  title = {Screening and surveillance practices for Multiple Endocrine Neoplasia type 1‐related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence ( ENETS CoE )—An ENETS MEN1 task force questionnaire study},
  journal = {Journal of Neuroendocrinology},
  year = {2025},
  volume = {37},
  number = {1},
  doi = {10.1111/jne.13468}
}
Kostenlos starten →